Coprococcus

A Gram-positive, obligate anaerobic genus within the lachnospiraceae family (Firmicutes phylum). Coprococcus is one of the most important butyrate-producing commensals in the human gut and has gained particular attention as the "happiness bug" — one of very few taxa directly linked to mental health outcomes through population-level studies. Key species include C. eutactus and C. catus, both prolific short chain fatty acids producers.

Role in Gut Ecosystem

  • Primary butyrate producer via the butyryl-CoA:acetate CoA-transferase pathway, generating the most potent anti-inflammatory SCFA in the colon.
  • C. catus also produces significant propionate via the acrylate pathway, making it one of few organisms that produces both butyrate and propionate.
  • Contributes to colonization resistance and gut barrier maintenance through butyrate-mediated upregulation of tight junction proteins and mucin production.
  • Cross-feeds with acetate producers and mucin-degrading bacteria like akkermansia muciniphila in the healthy gut fermentation network.

The "Happiness Bug" -- Mental Health Link

  • The landmark Valles-Colomer 2019 study identified Coprococcus (alongside faecalibacterium prausnitzii) as consistently depleted in individuals with depression, even after controlling for antidepressant use — one of the first population-scale microbiome-mental health associations.
  • Coprococcus produces DOPAC (3,4-dihydroxyphenylacetic acid), a dopamine metabolite, providing a plausible mechanism for its mental health associations via the gut brain axis.
  • Consistently decreased in autism spectrum disorder youth across multiple observational reviews [1].
  • Depleted in schizophrenia patients alongside other SCFA producers, consistent with the dysbiosis-inflammation-neurotransmitter axis in psychotic disorders [2] [3].

Sensitivity to Heavy Metals

  • Coprococcus is among the SCFA-producing taxa most sensitive to heavy metals toxicity, particularly cadmium and lead [4].
  • Lead exposure depletes Coprococcus, contributing to the ASD-metal-microbiome triad where Pb-induced loss of butyrate producers may exacerbate neurodevelopmental symptoms [5].
  • Its cobalt/B12-dependent metabolic pathways make it vulnerable to metal competition and displacement by heavy metals at enzyme active sites.

Disease Associations

Depression and Mental Health

  • Depleted in major depressive disorder; DOPAC production links it mechanistically to dopaminergic signaling.

Multiple Sclerosis

  • Reduced 3.4-fold in MS patients compared to healthy controls in the Saresella 2020 study, part of the dramatic Lachnospiraceae depletion that characterizes MS dysbiosis [6].
  • Loss correlates with reduced serum butyric acid and increased gut barrier permeability (elevated LPS and I-FABP).

Inflammatory Bowel Disease

  • Depleted in both Crohn's disease and ulcerative colitis, consistent with the general loss of butyrate producers in IBD.

Cardiovascular Disease

  • Coprococcus (Coprococcus1) is causally protective against coronary artery disease (OR=0.867) in MR analysis [7].

Colorectal Cancer

  • Depleted in CRC; part of the butyrate-producing consortium lost during tumorigenesis [8].

Ovarian Cancer

  • Altered Coprococcus abundance contributes to the diagnostic gut microbiome signature distinguishing ovarian tumor patients from healthy controls, consistent with the broad depletion of butyrate producers across gynecological cancers [9].

Chronic Kidney Disease

  • Depleted as part of the broader loss of butyrate-producing consortia in CKD; reduced SCFA availability contributes to uremic toxin accumulation and gut-kidney axis dysfunction [10] [11].

Key Metabolites

  • Butyrate — primary product; HDAC inhibitor, anti-inflammatory, gut barrier protectant
  • Propionate — produced by C. catus via acrylate pathway; metabolic regulator
  • DOPAC — dopamine metabolite; potential mediator of gut-brain mental health effects

Connections

  • faecalibacterium prausnitzii — fellow butyrate producer; co-depleted in depression, IBD, and MS
  • short chain fatty acids — one of the most important butyrate producers in the human gut
  • gut brain axis — DOPAC production links gut fermentation to dopaminergic neurotransmission
  • multiple sclerosis — dramatically depleted; loss contributes to barrier dysfunction
  • autism spectrum disorder — depleted in ASD; lead exposure may drive this depletion
  • lead — particularly sensitive to Pb; metal-induced loss may mediate neurobehavioral effects
  • cardiovascular disease — causally protective against CAD per MR evidence
  • colorectal cancer — depleted; loss removes tumor-suppressive butyrate HDAC inhibition
  • dorea — Lachnospiraceae relative with opposite disease pattern (enriched in disease)

References (11)

  1. . romano 2023 gut microbiome children mental health umbrella review
  2. . yan 2022 gut microbiome schizophrenia zhejiang china 16s
  3. . patrono 2021 schizophrenia gut microbiota optogenetics nmda gaba
  4. . zhu 2024 toxic essential metals gut microbiota
  5. . tizabi 2023 lead gut microbiota asd
  6. . saresella 2020 fatty acids dysbiosis inflammation ms
  7. . dai 2024 gut microbiota cvd bidirectional mr
  8. . sambruni 2023 colon cancer microbiome rna seq reconstruction
  9. . gong 2025 gut microbiota diagnostic ovarian tumor
  10. . gao 2021 butyrate producing microbiota reduced ckd
  11. . he 2024 gut microbial scfas ckd